Oncoheroes Biosciences is a biotechnology company dedicated to developing and commercializing new therapies for pediatric cancers. The company operates in the pediatric oncology market, focusing on identifying and validating novel precision oncogenic targets to create effective drug combinations. Oncoheroes partners with leading research institutions, such as Hopp Children's Cancer Center Heidelberg KiTZ, to test and advance their lead compounds, including Volasertib, which shows promise in treating various pediatric cancers like Rhabdomyosarcoma. The business model involves in-licensing clinical-stage or near-clinical-stage assets with the potential to cure pediatric cancers, conducting in-house research at their Barcelona Science Park PCB laboratory, and establishing external collaborations to generate a pipeline of new intellectual property projects. Revenue is generated through donations, investments, and the commercialization of their developed therapies.

Keywords: Pediatric oncology, drug development, precision targets, Volasertib, clinical-stage assets, cancer research, biotechnology, pediatric screening, Barcelona Science Park, novel therapies.